In the central line bloodstream initiative, CTMC is monitoring procedures for administering central lines and is collecting data from the time each central line is inserted into the patient to when it is removed. On a monthly basis, Johns Hopkins University evaluates the data and calculates the infection rate based on the number of central lines that are put in, number of infections that occur, and the number of days a patient is in the ICU.
“Johns Hopkins is one of the most prestigious medical research institutions in the United States, and we are thrilled to partner with them on this study,” said Clay DeStefano, Director of Public Relations & Marketing for CTMC. “Our goal is to provide the highest level of patient care in Central Texas, and the best way to ensure that we meet this goal is to do ongoing clinical research and testing, and to use the outcomes to perfect our practices.”
DeStefano noted that CTMC has always monitored its procedures in an effort to continuously improve the level of care provided to patients and their families. “The goal is always to maintain the lowest infection rate possible—zero,” said DeStefano. With inclusion in the byline of a national research study with Johns Hopkins University, CTMC is demonstrating that it remains committed to improving the collaborative environment of the hospital and providing the highest quality of care for patients and their families.